Irish Industry Press
SEE OTHER BRANDS

Top industries and services news from Ireland

Irish Industry Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Irish Industry Press.

Press releases published on August 7, 2025

Thermahood TH120 M – New Fire-Rated Solution for Recessed Lights, Downlights & Speakers

Thermahood TH120 M – New Fire-Rated Solution for Recessed Lights, Downlights & Speakers

UNITED KINGDOM, August 7, 2025 /⁨EINPresswire.com⁩/ -- Thermahood is proud to announce that its TH120 M — the robust metal variant of its popular downlight cover — can now be used to achieve 30- and 60-minute fire-rating. Designed for use with recessed …

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes DUBLIN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- …

Changes in Nokia Corporation's own shares

Changes in Nokia Corporation's own shares

Nokia Corporation Stock Exchange Release 7 August 2025 at 14:30 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 449 890 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of …

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Nokia Oyj Pörssitiedote 7.8.2025 klo 14.30 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 449 890 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …

GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates

GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates

Global pivotal program initiation on track for 2026 Engagement with FDA on GH001 IND complete response ongoing The fully completed Open-Label Extension analysis confirms a 73% remission rate at 6 months with infrequent treatment visits and no psychotherapy …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions